Target intelligence / Profile preview

Epithelial cell junction

Molecular classification
Other
01

Overview

Epithelial cell junctions are specialized protein complexes that provide structural integrity and regulate communication between adjacent epithelial cells (StatPearls, 2023). They consist of four primary types: tight junctions, adherens junctions, desmosomes, and gap junctions, which collectively maintain the epithelial barrier and regulate paracellular transport (Nature Reviews Molecular Cell Biology, 2014). These junctions are critical for maintaining cell polarity and tissue homeostasis, and their disruption is a key feature in various pathologies, including cancer metastasis and inflammatory diseases (Journal of Cell Science, 2017). In oncology, specific components like Claudin 18.2 are targeted by monoclonal antibodies such as Zolbetuximab to treat gastric and gastroesophageal cancers (The Lancet Oncology, 2021). Additionally, therapeutic agents like Larazotide aim to regulate tight junction permeability to treat autoimmune conditions such as celiac disease (American Journal of Gastroenterology, 2015). Understanding the molecular composition and regulation of these junctions is essential for developing strategies to enhance drug delivery or restore barrier function in chronic inflammatory states.

Other names
Intercellular junctionCell-cell junctionJunctional complex
02

Mechanism of action

Modulation of paracellular permeability, Targeted cytotoxicity, Restoration of barrier function

03

Biological functions

Signal transductionOther
04

Disease associations

CancerInflammationInfectionOther
05

Safety considerations

Loss of barrier integrityIncreased risk of infectionOff-target tissue damage
06

Interacting drugs

Zolbetuximab

3 more in the full profile.

07

Biomarkers

E-cadherin expressionClaudin-18.2 expressionTransepithelial electrical resistance (TEER)

Beyond the preview

Go deeper on Epithelial cell junction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epithelial cell junction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call